Settling Plate Test Procedure: Microbiological Monitoring Protocol for Cleanrooms and Controlled Env

The settling plate test is a passive microbiological monitoring method used to quantify airborne viable contamination in cleanrooms, sterile manufacturing areas, and other controlled environments. This article presents a complete settling plate test procedure based on GB/T 16294-2010, ISO 14698-1, and current GMP requirements, covering sampling point layout, exposure conditions, incubation, colony counting, and grade-specific acceptance limits.

Technical Overview

The settling plate test, also known as passive air sampling or the exposure plate method, is a standardized microbiological procedure used to evaluate the level of airborne viable particles in cleanrooms and controlled environments. The method relies on the natural gravitational deposition of microbe-carrying particles onto the exposed surface of a sterile culture medium over a defined period. Following incubation, colonies developing on the agar surface are counted and reported as colony forming units (CFU) per plate per exposure duration.

In the pharmaceutical industry, the settling plate test is a core component of the environmental monitoring program required by Good Manufacturing Practice (GMP) regulations and is typically performed alongside active air sampling, surface contact plate sampling, and personnel monitoring. The procedure is governed primarily by GB/T 16294-2010, which specifies the test method for settling microbes in cleanrooms of the pharmaceutical industry, as well as ISO 14698-1 for biocontamination control and the cleanroom grade limits defined in GMP annexes and ISO 14644-1 classification frameworks.

Because the method is non-mechanical, inexpensive, and directly reflects microbial deposition onto critical product-contact surfaces, it is considered one of the most representative indicators of contamination risk in aseptic processing areas, particularly when performed under dynamic (operational) conditions.

Testing Samples

Pharmaceutical Cleanroom Air

Air in sterile and non-sterile pharmaceutical manufacturing areas is the primary test object, covering Grade A, B, C, and D environments as defined by GMP. Typical monitored locations include aseptic filling zones, stopper bowls, preparation rooms, weighing and dispensing areas, lyophilization loading areas, and material transfer airlocks.

Medical Device Manufacturing Environments

Air in cleanrooms and local protection zones used for the production of sterile single-use devices, implants, and terminally sterilized products, where airborne bioburden must be controlled and periodically verified.

Healthcare and Laboratory Facilities

Air in hospital operating theatres, isolation wards, pharmaceutical preparation units, cell processing laboratories, and biosafety laboratories where microbiological cleanliness must be demonstrated or periodically verified.

Food, Cosmetic, and Biotechnology Production Areas

Air in controlled production zones for foods, beverages, cosmetics, and biological products, where airborne microbial contamination can directly affect product safety, shelf life, and batch release decisions.

Testing Items

The settling plate test primarily determines the following microbiological indicators:

• Total viable aerobic bacterial count, expressed as CFU per settle plate per exposure period (typically per 4 hours per GMP).
• Fungal count (yeasts and molds), determined using fungal-selective media where the monitoring program requires differentiation of fungal contamination.
• Time-averaged deposition rate, used to trend contamination behavior over production campaigns and to support contamination control strategy evaluations.
• Media performance verification, including sterility checks of unexposed plates (negative controls) and growth promotion testing of inoculated plates (positive controls).

Testing Methods

Equipment and Media Preparation

Standard 90 mm diameter disposable or reusable petri dishes filled with approximately 10 mL of Tryptone Soy Agar (TSA) or Soybean Casein Digest Agar are used for total aerobic counts. Sabouraud Dextrose Agar (SDA) may be used for fungal monitoring. All media must be sterilized, aseptically poured or purchased as pre-poured irradiated plates, and verified by growth promotion testing in accordance with pharmacopoeial requirements. Where residual disinfectants are present in the environment, media containing appropriate neutralizers should be selected.

Sampling Point Layout

The minimum number of sampling points is determined according to the cleanroom area, with GB/T 16294-2010 specifying that the minimum number of points equals the square root of the room area in square meters, and no fewer than two points should be used even in small rooms. Additional points must be positioned at critical risk locations, including positions directly exposed to product, along airflow paths, and near personnel activities. Sampling points are typically positioned at working height, between 0.8 m and 1.5 m above the floor, or at the actual product exposure height.

Testing Condition Selection

Testing may be performed under two defined conditions:

• Static (as-built or at-rest) testing, conducted after cleaning, disinfection, and completion of the self-purification period, without personnel or production activity.
• Dynamic (operational) testing, conducted during actual production with normal personnel presence and intervention simulation, which provides the most meaningful risk assessment for aseptic processes.

Exposure Procedure

The procedure is executed as follows:

• Verify that environmental parameters, including temperature, relative humidity, and pressure differentials, are within specified limits before sampling.
• Record lot numbers, exposure start times, locations, and operators for each plate to ensure full traceability.
• Place the settle plate at the designated location, remove the lid without touching the agar surface, and place the lid face-down beside the plate to avoid accidental contamination.
• Expose the agar surface for the defined period. Under GMP monitoring, exposure of up to 4 hours is permitted; under GB/T 16294-2010 static testing, an exposure of not less than 30 minutes is commonly applied. Exposure must not cause the medium to dry out or crack.
• At the end of exposure, replace the lid, retrieve the plate aseptically, and transfer it to incubation promptly.
• Expose unopened control plates alongside the test batch as negative controls to confirm media sterility.

Incubation and Colony Counting

TSA plates are inverted and incubated at 30 to 35 degrees Celsius for not less than 48 hours (typically 48 to 72 hours) for bacterial enumeration. Fungal plates on SDA are incubated at 20 to 25 degrees Celsius for 5 to 7 days. After incubation, colonies are counted using a colony counter or manual counting under standardized lighting, and results are recorded per plate and per location.

Result Evaluation and Acceptance Limits

Counts are compared against the alert and action limits defined in the environmental monitoring program. The commonly applied GMP settling plate limits for a 4-hour exposure are:

• Grade A: fewer than 1 CFU per plate.
• Grade B: not more than 5 CFU per plate.
• Grade C: not more than 50 CFU per plate.
• Grade D: not more than 100 CFU per plate.

Results exceeding alert limits require investigation under the environmental deviation procedure, while results exceeding action limits require documented root cause analysis, corrective and preventive actions, impact assessment on product batches, and increased monitoring frequency until results return to a controlled state.

Applications

The settling plate test procedure is applied across multiple regulated and hygiene-critical sectors:

• Sterile pharmaceutical manufacturing, including aseptic filling, stoppering, and lyophilization loading operations.
• Validation and periodic requalification of cleanrooms during commissioning, after modifications, and following major maintenance.
• Routine environmental monitoring programs supporting batch release and media fill simulation studies.
• Medical device cleanrooms producing terminally sterilized or aseptically processed products.
• Hospital operating theatres, sterile compounding pharmacies, and blood processing facilities.
• Food, beverage, and cosmetic production environments requiring microbiological air quality control.
• Contract manufacturing and accredited third-party laboratories performing cleanroom certification and compliance verification for clients.

FAQ

What is the difference between the settling plate method and active air sampling?

The settling plate method is a passive technique that captures only particles that naturally deposit onto the agar surface by gravity, reflecting actual contamination deposited onto surfaces. Active air sampling uses a calibrated device to draw a known volume of air through or onto the medium, providing a quantitative result per cubic meter of air. GMP programs require both methods because they measure complementary contamination characteristics.

How long should settle plates be exposed?

Under GMP monitoring, exposure of up to 4 hours is standard, and for Grade A zones shorter exposure with validated limits may be justified. Under GB/T 16294-2010 static testing, exposure of at least 30 minutes is typical. The exposure time must be validated to ensure the agar surface does not desiccate, which would impair microbial recovery.

What culture media are used for the settling plate test?

Tryptone Soy Agar (TSA), also known as Soybean Casein Digest Agar, is the standard medium for total aerobic bacterial counts. Sabouraud Dextrose Agar is used where fungal monitoring is required. Media containing neutralizers are recommended in environments with residual disinfectant activity.

Why must negative and positive controls be included?

Negative controls confirm that the media and handling procedures are free from contamination, while positive controls and growth promotion tests verify that the media can support the growth of target microorganisms. These controls are required to ensure the validity of the test results.

What actions are required when results exceed limits?

A documented investigation must be initiated, including review of cleaning and disinfection records, HVAC and pressure differential data, personnel behavior, and sampling technique. Root cause analysis, corrective and preventive actions, product impact assessment, and enhanced monitoring must be completed, with trending reviewed by the quality unit before closure.

How frequently should settling plate monitoring be performed?

Frequency is defined by the contamination control strategy and risk assessment of each facility. Grade A and Grade B areas supporting aseptic processes are typically monitored every shift or every production session, while lower grade areas are monitored at reduced, risk-based frequencies.